Clinical Trials on
Gamma Oryzanol & formulations with Gamma Oryzanol as the active ingredient on Hypertension
Title Of The Study: Curative Effect Observation of Oryzanol and Irbesartan Combination Therapy for Urban and Rural Community Hypertension
Objective To investigate the curative effect of oryzanol combined with irbesartan on patients with hypertension, in order to achieve the aim of enhancing people health situation. Methods Eighty two patients with hypertension who seek treatment in hospital in the suburban area linking the urban and rural were divided into two groups, each group had 41 patients. The control group used irbesartan, the experimental group used oryzanol combined with irbesartan. Results The two groups had few adverse effects, the total efficient rate of the experimental group was significantly higher than that of the control group (P < 0.01), systolic and diastolic blood pressure improvement were better than that of the control group (P < 0.05). Conclusion The curative effect of oryzanol combined with irbesartan hypertension is obvious, which can improve the health level of community population, be worth popularizing extensively.
For Study Link: Click Here
Title Of The Study: The Clinical Research of Oryzanol in the Assist Treatment
of Primary Hypertension
Objective: To observe the curative effect of oryzanol in adjuvant treatment of primary mild and moderate hypertension. Methods: 82 patients with primary mild and moderate hypertension were randomly divided into two groups, 42 patients in the treatment group were given oryzanol tablets plus nifedipine Dipine sustained-release tablets; 40 patients in the control group were given only nifedipine sustained-release tablets; both groups were treated for 2 months, and the final decrease range of systolic and diastolic blood pressure was evaluated. Results: The systolic and diastolic blood pressure in the treatment group The decrease rate was more obvious, and compared with the control group, there was a significant difference (P<0.05), and the adverse reactions in the two groups were mild. Conclusion: Oryzanol tablets plus nifedipine sustained-release tablets in the treatment of primary mild and moderate high HYPERTENSION.
For Study Link: Click Here
